ReviewOncoimmunology

Secretory pathways generating immunosuppressive NKG2D ligands: New targets for therapeutic intervention.

Aroa Baragaño Raneros et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.